Castellano M, Rizzoni D, Beschi M, Muiesan M L, Porteri E, Bettoni G, Salvetti M, Cinelli A, Zulli R, Agabiti-Rosei E
U.O.P. Scienze Mediche, University of Brescia, Italy.
J Hypertens. 1995 Oct;13(10):1153-61. doi: 10.1097/00004872-199510000-00010.
To examine the cardiovascular effects of acute systemic nitric oxide synthesis inhibition in humans in relation to the possible involvement of changes in sympathetic nervous system activity or in the baroreceptor reflex.
Placebo or NG-monomethyl-L-arginine (250 mg by intravenous infusion for 5 min) was administered to seven healthy male volunteers according to a random, double-blind sequence.
Blood pressure and heart rate were measured non-invasively using a Finapres device from 20 min before to 80 min after starting infusion; beat-to-beat variability of blood pressure, pulse interval and systolic blood pressure and pulse interval covariation were assessed by means of spectral and sequence analysis methods. Under basal conditions and 15 min and 60 min after infusion, we measured stroke volume and indices of cardiac systolic and diastolic function by echocardiography, forearm blood flow by strain-gauge venous occlusion plethysmography, and plasma catecholamine levels.
Compared with placebo, administration of NG-monomethyl-L-arginine caused a transient increase in blood pressure and reduction in heart rate. Stroke volume and indices of cardiac function did not change significantly, whereas cardiac index and forearm blood flow were significantly reduced after 15 min. Spectral analysis of blood pressure and pulse interval showed a significant reduction of power spectral density in the low frequencies (0.03-0.15 Hz) that persisted 60 min after infusion. The plasma noradrenaline level was significantly reduced after 15 min. No change in baroreflex engagement or sensitivity was detected by the cross-spectral or the sequence method.
Acute systemic nitric oxide synthesis inhibition transiently increases blood pressure and reduces heart rate and cardiac index. The acute hypertensive response to NG-monomethyl-L-arginine is dependent neither on sympathetic nervous system activity, which is probably reduced as a consequence of baroreceptor reflex activation, nor on baroreceptor reflex sensitivity, which is not impaired.
研究急性系统性一氧化氮合成抑制对人体心血管系统的影响,以及交感神经系统活动变化或压力感受器反射可能参与其中的情况。
按照随机、双盲顺序,对7名健康男性志愿者给予安慰剂或NG-单甲基-L-精氨酸(静脉输注250毫克,持续5分钟)。
使用Finapres设备在开始输注前20分钟至输注后80分钟无创测量血压和心率;通过频谱和序列分析方法评估血压的逐搏变异性、脉搏间期以及收缩压与脉搏间期的协变。在基础状态下以及输注后15分钟和60分钟,通过超声心动图测量每搏输出量和心脏收缩与舒张功能指标,通过应变片静脉阻塞体积描记法测量前臂血流量,以及测量血浆儿茶酚胺水平。
与安慰剂相比,给予NG-单甲基-L-精氨酸导致血压短暂升高和心率降低。每搏输出量和心脏功能指标无显著变化,而心脏指数和前臂血流量在15分钟后显著降低。血压和脉搏间期的频谱分析显示低频(0.03 - 0.15赫兹)功率谱密度显著降低,输注后60分钟仍持续存在。15分钟后血浆去甲肾上腺素水平显著降低。通过互谱或序列方法未检测到压力反射参与或敏感性的变化。
急性系统性一氧化氮合成抑制会短暂升高血压、降低心率和心脏指数。对NG-单甲基-L-精氨酸的急性高血压反应既不依赖于交感神经系统活动(可能因压力感受器反射激活而降低),也不依赖于未受损的压力感受器反射敏感性。